SlideShare a Scribd company logo
1 of 18
Comprehensive
Drug Abuse Prevention
and Control Act
(Controlled Substance
Act, 1970)
       BY SAKSHI DAHIYA
       MPHARM(DRA) 1ST SEM
                             1
Key points:-
• “Federalization” or
 “nationalization” of drug control
• This act forms the basis of
     federal    government
 enforcement efforts.
 Defines a drug-dependent person.
 Established five categories of scheduled
  drugs (controlled substances).
 Provides for strict regulation of controlled
  substances
                                           2
1970 - Comprehensive Drug Abuse
 Prevention and Control Act - consolidates
 previous drug laws and reduces penalties
 for marijuana possession. It also
 strengthens law enforcement by allowing
 police to conduct "no-knock" searches
The Drug Enforcement Agency (DEA) was
 formed to enforce the laws concerning
 narcotics and their distribution
 Created a stair-step schedule of
 controlled substances
                                        3
What is a Drug?
A drug may be any
ingestive substance
that has a noticeable
effect upon the mind or
body.
                          4
This act divided substances with
abuse potential into categories
based on the degree of their abuse
potential and clinical usefulness
Schedules I, II, III, IV, V which
classify psychoactive drugs
according to degree of
psychoactivity and abuse potential

                               5
Schedule I substances have high-abuse
 potential and no currently approved
 medicinal uses; they cannot be prescribed.
Schedule II substances have high-abuse
 potential but are approved for medical
 uses and can be prescribed.
Schedule I–V reflects the likelihood of
 abuse and clinical usefulness




                                              6
Controlled Substance Act
Schedule I -         •   heroin
(MOST DANGEROUS) •       LSD
Controlled           •
substances that have
                         mescaline
no established       •   peyote
medical usage,       •   methaqualone
cannot be used
safely, and have
                     •   psilocybin
great potential for  •   marijuana
abuse. This schedule •   hashish
includes:
                     •   other specified
                            hallucinogens
                                            7
Controlled Substance Act
Schedule II -
Substances defined as
drugs with high abuse
potential for which there   •   opium
is currently accepted       •   morphine
pharmacological or          •   codeine
medical use. Most are       •   cocaine
considered addictive.       •   PCP
Examples:                   •   other
                                  derivatives
                                                8
Controlled Substance Act
Schedule III -

This schedule involves
lower abuse potential
than drugs in Schedules
I or II. They have an      • Many drugs
accepted medical use,         found in
but may lead to high
level of psychological        Schedule II,
dependence or to              but in
moderate or low physical      derivative or
dependence. Examples          diluted form.
include:
                                              9
Controlled Substance Act
Schedule IV -
These have a relatively
low potential for abuse,
are useful in
established medical        • depressants
treatments, and involve    • minor
only limited risk of          tranquilizers
psychological or           • some
physical dependency.          stimulants
Examples include:
                                          10
Controlled Substance Act
Schedule V -
(Least Dangerous)
Prescription drugs    • Cough medicines
with low potential       containing opium,
for abuse and only       morphine, or
limited possibility      codeine
for psychological     • Anti-diarrhetics
or physical              containing opium,
dependence.              morphine, or
Examples:                codeine.
                                       11
 It is a United States federal law  requires
the pharmaceutical industry to maintain
physical security and strict record keeping
for certain types of drugs. 
 The CSA is the federal U.S. drug policy
 under which the manufacture, importation,
possession, use and distribution of certain
substances is regulated.
This law is a consolidation of numerous laws
regulating the manufacture and distribution
of narcotics, stimulants, depressants, 
hallucinogens, anabolic steroids, and
chemicals used in the illicit production of
controlled substances. The act also provides
a mechanism for substances to be controlled,
added to a schedule, decontrolled, removed
from control, rescheduled, or transferred
from one schedule to another.               12
Proceedings to add, delete, or change
 the schedule of a drug or other
 substance may be initiated by the 
 Drug Enforcement Administration
  (DEA), the
 Department of Health and Human Service
  (HHS)
The DEA also may begin an investigation
 of a drug at any time based upon
 information received from law enforce
 -ment laboratories, state,local law
 enforcement andregulatory agencies, or
                                   13
DEA(data)                  HHS
Administrator              request


   drug to           Assistant
 be controlled    secretaryHealth HHS
or not

          commissioner     Evaluation from
              FDA              NIDA

                                         14
Once the DEA has collected the
necessary data, the Administrator of the
Drug Enforcement Association, by
authority of the Attorney General,
requests from the HHS a scientific and
medical evaluation and recommendation as
to whether the drug or other substance
should be controlled or removed from
control. This request is sent to the
Assistant Secretary of Health of the
HHS,  Then, the HHS solicits information
from the Commissioner of the Food and
Drug Administration and
                                     15
and evaluations and recommendations
 from the National Institute on Drug
 Abuse,  and on occasion, from the
 scientific and medical community.
 The Assistant Secretary, by authority
 of the Secretary, compiles the
 information and transmits back to the
 DEA a medical and scientific evaluation
 regarding the drug or other substance,
 a recommendation as to whether the
 drug should be controlled, and in what
 schedule it should be placed.
                                       16
Every schedule otherwise requires finding and
 specifying the "potential for abuse" before a
 substance can be placed in that schedule.[16]The
 specific classification of any given drug or other
 substance is usually a source of controversy, as is
 the purpose and effectiveness of the entire
 regulatory scheme.
"The term 'controlled substance' means a drug or
 other substance, or immediate precursor, included
 in schedule I, II, III, IV, or V . The term does not
 include distilled spirits, wine, malt beverages, or
 tobacco, as those terms are defined or used in
 subtitle E of the Internal Revenue Code of
 1986." 21 U.S.C. § 802(6)

                                                  17
18

More Related Content

What's hot

Factors affecting medication adherence
Factors affecting medication adherence Factors affecting medication adherence
Factors affecting medication adherence Ramesh Ganpisetti
 
Introduction to clinical pharmacy practice
Introduction to clinical pharmacy practiceIntroduction to clinical pharmacy practice
Introduction to clinical pharmacy practiceAimen Salman
 
ROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTION
ROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTIONROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTION
ROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTIONAnindya Banerjee
 
Professional relations and practices of hospital pharmacis
Professional relations and practices of hospital pharmacisProfessional relations and practices of hospital pharmacis
Professional relations and practices of hospital pharmacisvikasaagrahari007
 
Poison information center (Structural Organization and functions)
Poison information center (Structural Organization and functions)Poison information center (Structural Organization and functions)
Poison information center (Structural Organization and functions)Dr. Abhimanyu Prashar
 
Pharmacoeconomics 22 feb 2018
Pharmacoeconomics 22 feb 2018Pharmacoeconomics 22 feb 2018
Pharmacoeconomics 22 feb 2018Dr Roohana Hasan
 
Inhibition and induction of drug metabolism
Inhibition and induction of drug metabolismInhibition and induction of drug metabolism
Inhibition and induction of drug metabolismDr. Ramesh Bhandari
 
QSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDQSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDGagangowda58
 
An overveiw on regulation of otc drug product in different country
An overveiw on regulation of otc drug product in different countryAn overveiw on regulation of otc drug product in different country
An overveiw on regulation of otc drug product in different countryNitin Patel
 
Drug development process
Drug development processDrug development process
Drug development processKarthiga M
 
Narcotic drugs and psychotropic substance act 1985
Narcotic drugs and psychotropic substance act 1985Narcotic drugs and psychotropic substance act 1985
Narcotic drugs and psychotropic substance act 1985gururaj lulkarni
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
PharmacoepidemiologyDivjyot Kaur
 
Drug information and poison information
Drug information and poison informationDrug information and poison information
Drug information and poison informationTHUSHARA MOHAN
 
Opportunities for Pharmacy Practice Research in Community Setting
Opportunities for Pharmacy Practice Research in Community SettingOpportunities for Pharmacy Practice Research in Community Setting
Opportunities for Pharmacy Practice Research in Community SettingPharmCare Research Group USM
 
Narcotic and Psychotropic Substance act 1985
Narcotic and Psychotropic Substance act 1985Narcotic and Psychotropic Substance act 1985
Narcotic and Psychotropic Substance act 1985Prakash Mali
 

What's hot (20)

Factors affecting medication adherence
Factors affecting medication adherence Factors affecting medication adherence
Factors affecting medication adherence
 
Medication history
Medication historyMedication history
Medication history
 
Introduction to clinical pharmacy practice
Introduction to clinical pharmacy practiceIntroduction to clinical pharmacy practice
Introduction to clinical pharmacy practice
 
ROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTION
ROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTIONROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTION
ROLE OF PHARMACOVIGILANCE AGAINST ADVERSE DRUG REACTION
 
Professional relations and practices of hospital pharmacis
Professional relations and practices of hospital pharmacisProfessional relations and practices of hospital pharmacis
Professional relations and practices of hospital pharmacis
 
Poison information center (Structural Organization and functions)
Poison information center (Structural Organization and functions)Poison information center (Structural Organization and functions)
Poison information center (Structural Organization and functions)
 
Pharmacoeconomics 22 feb 2018
Pharmacoeconomics 22 feb 2018Pharmacoeconomics 22 feb 2018
Pharmacoeconomics 22 feb 2018
 
Inhibition and induction of drug metabolism
Inhibition and induction of drug metabolismInhibition and induction of drug metabolism
Inhibition and induction of drug metabolism
 
QSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDQSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADD
 
An overveiw on regulation of otc drug product in different country
An overveiw on regulation of otc drug product in different countryAn overveiw on regulation of otc drug product in different country
An overveiw on regulation of otc drug product in different country
 
Drug development process
Drug development processDrug development process
Drug development process
 
Rational drug use
Rational  drug  useRational  drug  use
Rational drug use
 
Narcotic drugs and psychotropic substance act 1985
Narcotic drugs and psychotropic substance act 1985Narcotic drugs and psychotropic substance act 1985
Narcotic drugs and psychotropic substance act 1985
 
Pharmacoepidemiology
PharmacoepidemiologyPharmacoepidemiology
Pharmacoepidemiology
 
Hospital pharmacy ppt
Hospital pharmacy pptHospital pharmacy ppt
Hospital pharmacy ppt
 
Drug information and poison information
Drug information and poison informationDrug information and poison information
Drug information and poison information
 
Opportunities for Pharmacy Practice Research in Community Setting
Opportunities for Pharmacy Practice Research in Community SettingOpportunities for Pharmacy Practice Research in Community Setting
Opportunities for Pharmacy Practice Research in Community Setting
 
Non compliance
Non complianceNon compliance
Non compliance
 
Pharmacoeconomics
PharmacoeconomicsPharmacoeconomics
Pharmacoeconomics
 
Narcotic and Psychotropic Substance act 1985
Narcotic and Psychotropic Substance act 1985Narcotic and Psychotropic Substance act 1985
Narcotic and Psychotropic Substance act 1985
 

Viewers also liked

Drug abuse ppt
Drug abuse pptDrug abuse ppt
Drug abuse pptDFC2011
 
Addressing drug use and changing legal and social
Addressing drug use and changing legal and socialAddressing drug use and changing legal and social
Addressing drug use and changing legal and socialGreg Chartier, PhD
 
Drugs PPT - sociology - shubham parsekar
Drugs PPT - sociology - shubham parsekarDrugs PPT - sociology - shubham parsekar
Drugs PPT - sociology - shubham parsekarShubham Parsekar
 
Drug development and regulation
Drug development and regulationDrug development and regulation
Drug development and regulationraj kumar
 
Birth & death information automation
Birth & death information automationBirth & death information automation
Birth & death information automationSaeed Siddik
 
The clinical establishments (registration and regulation) act 2010 and rules...
The clinical establishments (registration and  regulation) act 2010 and rules...The clinical establishments (registration and  regulation) act 2010 and rules...
The clinical establishments (registration and regulation) act 2010 and rules...Dr. Priyanka Srivastava
 
The Clinical Establishments (Registration & Regulation) Act mithun kherde
The Clinical Establishments (Registration & Regulation) Act mithun kherdeThe Clinical Establishments (Registration & Regulation) Act mithun kherde
The Clinical Establishments (Registration & Regulation) Act mithun kherdemithun.kherde
 
Clinical establishment act
Clinical establishment actClinical establishment act
Clinical establishment actShambhu N
 
Gas cylinder rule_2004
Gas cylinder rule_2004Gas cylinder rule_2004
Gas cylinder rule_2004GirishBarve
 
Drug Abuse PPT by nirav
Drug Abuse PPT by niravDrug Abuse PPT by nirav
Drug Abuse PPT by niravniravkd
 
"DRUG ABUSE" BETTER LATE THAN NEVER
"DRUG ABUSE" BETTER LATE THAN NEVER"DRUG ABUSE" BETTER LATE THAN NEVER
"DRUG ABUSE" BETTER LATE THAN NEVERsyakilahnorazmi
 
Drug Abuse and its Prevention
Drug Abuse and its PreventionDrug Abuse and its Prevention
Drug Abuse and its PreventionFrenz Delgado
 
Registration of births & deaths act ppt
Registration of births & deaths act pptRegistration of births & deaths act ppt
Registration of births & deaths act ppt Dr.Priyanka Phonde
 
Alcohol drug awareness
Alcohol drug awarenessAlcohol drug awareness
Alcohol drug awarenessRCIPS
 

Viewers also liked (20)

Drug abuse ppt
Drug abuse pptDrug abuse ppt
Drug abuse ppt
 
Drug addiction and drug abuse
Drug addiction and drug abuseDrug addiction and drug abuse
Drug addiction and drug abuse
 
Addressing drug use and changing legal and social
Addressing drug use and changing legal and socialAddressing drug use and changing legal and social
Addressing drug use and changing legal and social
 
Drugs & substance abuse at workplace
Drugs & substance abuse at workplaceDrugs & substance abuse at workplace
Drugs & substance abuse at workplace
 
Drugs PPT - sociology - shubham parsekar
Drugs PPT - sociology - shubham parsekarDrugs PPT - sociology - shubham parsekar
Drugs PPT - sociology - shubham parsekar
 
Drug development and regulation
Drug development and regulationDrug development and regulation
Drug development and regulation
 
Atomic energy
Atomic energyAtomic energy
Atomic energy
 
Birth & death information automation
Birth & death information automationBirth & death information automation
Birth & death information automation
 
Cotpa 03
Cotpa 03Cotpa 03
Cotpa 03
 
The clinical establishments (registration and regulation) act 2010 and rules...
The clinical establishments (registration and  regulation) act 2010 and rules...The clinical establishments (registration and  regulation) act 2010 and rules...
The clinical establishments (registration and regulation) act 2010 and rules...
 
The Clinical Establishments (Registration & Regulation) Act mithun kherde
The Clinical Establishments (Registration & Regulation) Act mithun kherdeThe Clinical Establishments (Registration & Regulation) Act mithun kherde
The Clinical Establishments (Registration & Regulation) Act mithun kherde
 
Clinical establishment act
Clinical establishment actClinical establishment act
Clinical establishment act
 
Gas cylinder rule_2004
Gas cylinder rule_2004Gas cylinder rule_2004
Gas cylinder rule_2004
 
Drug Abuse PPT by nirav
Drug Abuse PPT by niravDrug Abuse PPT by nirav
Drug Abuse PPT by nirav
 
"DRUG ABUSE" BETTER LATE THAN NEVER
"DRUG ABUSE" BETTER LATE THAN NEVER"DRUG ABUSE" BETTER LATE THAN NEVER
"DRUG ABUSE" BETTER LATE THAN NEVER
 
Drug abuse prathyusha
Drug abuse prathyushaDrug abuse prathyusha
Drug abuse prathyusha
 
Drug Abuse and its Prevention
Drug Abuse and its PreventionDrug Abuse and its Prevention
Drug Abuse and its Prevention
 
The pharmacy act
The pharmacy actThe pharmacy act
The pharmacy act
 
Registration of births & deaths act ppt
Registration of births & deaths act pptRegistration of births & deaths act ppt
Registration of births & deaths act ppt
 
Alcohol drug awareness
Alcohol drug awarenessAlcohol drug awareness
Alcohol drug awareness
 

Similar to Drug abuse & control act 1970 ppt dra2

Drugs & Society Chapter 3
Drugs & Society Chapter 3Drugs & Society Chapter 3
Drugs & Society Chapter 3Michelle Meyer
 
Chapter 3 Drugs & Society
Chapter 3 Drugs & SocietyChapter 3 Drugs & Society
Chapter 3 Drugs & SocietyMichelle Meyer
 
Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03Bryan
 
Acts related to addiction psychiatry
Acts related to addiction psychiatryActs related to addiction psychiatry
Acts related to addiction psychiatryDr. Sunil Suthar
 
Controlled drugs
Controlled drugsControlled drugs
Controlled drugsDarya Daoud
 
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxMRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxDimple Marathe
 
Investaigational drugs
Investaigational drugsInvestaigational drugs
Investaigational drugsSultan Alharbi
 
Pain meds powerpoint.1
Pain meds powerpoint.1Pain meds powerpoint.1
Pain meds powerpoint.1ageril
 
OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945
OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945
OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945Yamini Shah
 
MHRA and USFDA simultaneously data
MHRA and USFDA simultaneously dataMHRA and USFDA simultaneously data
MHRA and USFDA simultaneously data66VaibhavWaghchaure
 
Nstp prefinals documentation lyn2 copy
Nstp prefinals documentation lyn2   copyNstp prefinals documentation lyn2   copy
Nstp prefinals documentation lyn2 copyMary Lyn Enguerra
 
Overview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,indiaOverview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,indiashabana parveen
 
The Social Manace of Drug Addiction by Radion 8
The Social Manace of Drug Addiction by Radion 8The Social Manace of Drug Addiction by Radion 8
The Social Manace of Drug Addiction by Radion 8AubreyMaePedrosa1
 

Similar to Drug abuse & control act 1970 ppt dra2 (20)

Drug Schedules
Drug SchedulesDrug Schedules
Drug Schedules
 
Drug_Scheduling.pptx
Drug_Scheduling.pptxDrug_Scheduling.pptx
Drug_Scheduling.pptx
 
Drugs & Society Chapter 3
Drugs & Society Chapter 3Drugs & Society Chapter 3
Drugs & Society Chapter 3
 
Chapter 3 Drugs & Society
Chapter 3 Drugs & SocietyChapter 3 Drugs & Society
Chapter 3 Drugs & Society
 
Ethics chapter
Ethics chapterEthics chapter
Ethics chapter
 
Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03Hanson 10e Pp Ts Ch03
Hanson 10e Pp Ts Ch03
 
Drug schedules
Drug schedulesDrug schedules
Drug schedules
 
Drug scheduling in india
Drug scheduling in indiaDrug scheduling in india
Drug scheduling in india
 
Acts related to addiction psychiatry
Acts related to addiction psychiatryActs related to addiction psychiatry
Acts related to addiction psychiatry
 
Controlled drugs
Controlled drugsControlled drugs
Controlled drugs
 
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptxMRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
MRA201 T. Unit 1 Regulatory aspects of drugs and cosmetics unit 1.pptx
 
Investaigational drugs
Investaigational drugsInvestaigational drugs
Investaigational drugs
 
Pain meds powerpoint.1
Pain meds powerpoint.1Pain meds powerpoint.1
Pain meds powerpoint.1
 
OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945
OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945
OTC drugs (Amended rules) Drug and Cosmetic Act, 1940 & Rules,1945
 
MHRA and USFDA simultaneously data
MHRA and USFDA simultaneously dataMHRA and USFDA simultaneously data
MHRA and USFDA simultaneously data
 
Basic Introduction of drugs 1.pptx
Basic Introduction of drugs 1.pptxBasic Introduction of drugs 1.pptx
Basic Introduction of drugs 1.pptx
 
Nstp prefinals documentation lyn2 copy
Nstp prefinals documentation lyn2   copyNstp prefinals documentation lyn2   copy
Nstp prefinals documentation lyn2 copy
 
Pharma 1
Pharma 1Pharma 1
Pharma 1
 
Overview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,indiaOverview regulatory environment in usa,europe,india
Overview regulatory environment in usa,europe,india
 
The Social Manace of Drug Addiction by Radion 8
The Social Manace of Drug Addiction by Radion 8The Social Manace of Drug Addiction by Radion 8
The Social Manace of Drug Addiction by Radion 8
 

More from bdvfgbdhg

Scale up and post approval changes(supac)
Scale up and post approval changes(supac)Scale up and post approval changes(supac)
Scale up and post approval changes(supac)bdvfgbdhg
 
Priscription drug user free act......sn
Priscription drug user free act......snPriscription drug user free act......sn
Priscription drug user free act......snbdvfgbdhg
 
Medical device
Medical deviceMedical device
Medical devicebdvfgbdhg
 
Labeling in india
Labeling in indiaLabeling in india
Labeling in indiabdvfgbdhg
 
Registration procedure of drugs in european union
Registration procedure of drugs in european unionRegistration procedure of drugs in european union
Registration procedure of drugs in european unionbdvfgbdhg
 
National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)bdvfgbdhg
 
Central drug standard control organisation
Central drug standard control organisationCentral drug standard control organisation
Central drug standard control organisationbdvfgbdhg
 
Bulk active post approval changes
Bulk active post approval changesBulk active post approval changes
Bulk active post approval changesbdvfgbdhg
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillencebdvfgbdhg
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillencebdvfgbdhg
 

More from bdvfgbdhg (12)

Snda
SndaSnda
Snda
 
Scale up and post approval changes(supac)
Scale up and post approval changes(supac)Scale up and post approval changes(supac)
Scale up and post approval changes(supac)
 
Priscription drug user free act......sn
Priscription drug user free act......snPriscription drug user free act......sn
Priscription drug user free act......sn
 
Nppa
NppaNppa
Nppa
 
Medical device
Medical deviceMedical device
Medical device
 
Labeling in india
Labeling in indiaLabeling in india
Labeling in india
 
Registration procedure of drugs in european union
Registration procedure of drugs in european unionRegistration procedure of drugs in european union
Registration procedure of drugs in european union
 
National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)National pharmaceutical pricing athourity (nppa)
National pharmaceutical pricing athourity (nppa)
 
Central drug standard control organisation
Central drug standard control organisationCentral drug standard control organisation
Central drug standard control organisation
 
Bulk active post approval changes
Bulk active post approval changesBulk active post approval changes
Bulk active post approval changes
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillence
 
Post marketing servillence
Post marketing servillencePost marketing servillence
Post marketing servillence
 

Recently uploaded

ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4MiaBumagat1
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
Textual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSTextual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSMae Pangan
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfErwinPantujan2
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...JojoEDelaCruz
 
EMBODO Lesson Plan Grade 9 Law of Sines.docx
EMBODO Lesson Plan Grade 9 Law of Sines.docxEMBODO Lesson Plan Grade 9 Law of Sines.docx
EMBODO Lesson Plan Grade 9 Law of Sines.docxElton John Embodo
 
Oppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmOppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmStan Meyer
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataBabyAnnMotar
 
Millenials and Fillennials (Ethical Challenge and Responses).pptx
Millenials and Fillennials (Ethical Challenge and Responses).pptxMillenials and Fillennials (Ethical Challenge and Responses).pptx
Millenials and Fillennials (Ethical Challenge and Responses).pptxJanEmmanBrigoli
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...Postal Advocate Inc.
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parentsnavabharathschool99
 
The Contemporary World: The Globalization of World Politics
The Contemporary World: The Globalization of World PoliticsThe Contemporary World: The Globalization of World Politics
The Contemporary World: The Globalization of World PoliticsRommel Regala
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 
TEACHER REFLECTION FORM (NEW SET........).docx
TEACHER REFLECTION FORM (NEW SET........).docxTEACHER REFLECTION FORM (NEW SET........).docx
TEACHER REFLECTION FORM (NEW SET........).docxruthvilladarez
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
ClimART Action | eTwinning Project
ClimART Action    |    eTwinning ProjectClimART Action    |    eTwinning Project
ClimART Action | eTwinning Projectjordimapav
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptxmary850239
 

Recently uploaded (20)

ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4ANG SEKTOR NG agrikultura.pptx QUARTER 4
ANG SEKTOR NG agrikultura.pptx QUARTER 4
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
Textual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHSTextual Evidence in Reading and Writing of SHS
Textual Evidence in Reading and Writing of SHS
 
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptxINCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
INCLUSIVE EDUCATION PRACTICES FOR TEACHERS AND TRAINERS.pptx
 
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdfVirtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
Virtual-Orientation-on-the-Administration-of-NATG12-NATG6-and-ELLNA.pdf
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
ENG 5 Q4 WEEk 1 DAY 1 Restate sentences heard in one’s own words. Use appropr...
 
EMBODO Lesson Plan Grade 9 Law of Sines.docx
EMBODO Lesson Plan Grade 9 Law of Sines.docxEMBODO Lesson Plan Grade 9 Law of Sines.docx
EMBODO Lesson Plan Grade 9 Law of Sines.docx
 
Oppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and FilmOppenheimer Film Discussion for Philosophy and Film
Oppenheimer Film Discussion for Philosophy and Film
 
Measures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped dataMeasures of Position DECILES for ungrouped data
Measures of Position DECILES for ungrouped data
 
Paradigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTAParadigm shift in nursing research by RS MEHTA
Paradigm shift in nursing research by RS MEHTA
 
Millenials and Fillennials (Ethical Challenge and Responses).pptx
Millenials and Fillennials (Ethical Challenge and Responses).pptxMillenials and Fillennials (Ethical Challenge and Responses).pptx
Millenials and Fillennials (Ethical Challenge and Responses).pptx
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
 
Choosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for ParentsChoosing the Right CBSE School A Comprehensive Guide for Parents
Choosing the Right CBSE School A Comprehensive Guide for Parents
 
The Contemporary World: The Globalization of World Politics
The Contemporary World: The Globalization of World PoliticsThe Contemporary World: The Globalization of World Politics
The Contemporary World: The Globalization of World Politics
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
TEACHER REFLECTION FORM (NEW SET........).docx
TEACHER REFLECTION FORM (NEW SET........).docxTEACHER REFLECTION FORM (NEW SET........).docx
TEACHER REFLECTION FORM (NEW SET........).docx
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
ClimART Action | eTwinning Project
ClimART Action    |    eTwinning ProjectClimART Action    |    eTwinning Project
ClimART Action | eTwinning Project
 
4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx4.16.24 21st Century Movements for Black Lives.pptx
4.16.24 21st Century Movements for Black Lives.pptx
 

Drug abuse & control act 1970 ppt dra2

  • 1. Comprehensive Drug Abuse Prevention and Control Act (Controlled Substance Act, 1970) BY SAKSHI DAHIYA MPHARM(DRA) 1ST SEM 1
  • 2. Key points:- • “Federalization” or “nationalization” of drug control • This act forms the basis of federal government enforcement efforts. Defines a drug-dependent person. Established five categories of scheduled drugs (controlled substances). Provides for strict regulation of controlled substances 2
  • 3. 1970 - Comprehensive Drug Abuse Prevention and Control Act - consolidates previous drug laws and reduces penalties for marijuana possession. It also strengthens law enforcement by allowing police to conduct "no-knock" searches The Drug Enforcement Agency (DEA) was formed to enforce the laws concerning narcotics and their distribution  Created a stair-step schedule of controlled substances 3
  • 4. What is a Drug? A drug may be any ingestive substance that has a noticeable effect upon the mind or body. 4
  • 5. This act divided substances with abuse potential into categories based on the degree of their abuse potential and clinical usefulness Schedules I, II, III, IV, V which classify psychoactive drugs according to degree of psychoactivity and abuse potential 5
  • 6. Schedule I substances have high-abuse potential and no currently approved medicinal uses; they cannot be prescribed. Schedule II substances have high-abuse potential but are approved for medical uses and can be prescribed. Schedule I–V reflects the likelihood of abuse and clinical usefulness 6
  • 7. Controlled Substance Act Schedule I - • heroin (MOST DANGEROUS) • LSD Controlled • substances that have mescaline no established • peyote medical usage, • methaqualone cannot be used safely, and have • psilocybin great potential for • marijuana abuse. This schedule • hashish includes: • other specified hallucinogens 7
  • 8. Controlled Substance Act Schedule II - Substances defined as drugs with high abuse potential for which there • opium is currently accepted • morphine pharmacological or • codeine medical use. Most are • cocaine considered addictive. • PCP Examples: • other derivatives 8
  • 9. Controlled Substance Act Schedule III - This schedule involves lower abuse potential than drugs in Schedules I or II. They have an • Many drugs accepted medical use, found in but may lead to high level of psychological Schedule II, dependence or to but in moderate or low physical derivative or dependence. Examples diluted form. include: 9
  • 10. Controlled Substance Act Schedule IV - These have a relatively low potential for abuse, are useful in established medical • depressants treatments, and involve • minor only limited risk of tranquilizers psychological or • some physical dependency. stimulants Examples include: 10
  • 11. Controlled Substance Act Schedule V - (Least Dangerous) Prescription drugs • Cough medicines with low potential containing opium, for abuse and only morphine, or limited possibility codeine for psychological • Anti-diarrhetics or physical containing opium, dependence. morphine, or Examples: codeine. 11
  • 12.  It is a United States federal law  requires the pharmaceutical industry to maintain physical security and strict record keeping for certain types of drugs.   The CSA is the federal U.S. drug policy  under which the manufacture, importation, possession, use and distribution of certain substances is regulated. This law is a consolidation of numerous laws regulating the manufacture and distribution of narcotics, stimulants, depressants,  hallucinogens, anabolic steroids, and chemicals used in the illicit production of controlled substances. The act also provides a mechanism for substances to be controlled, added to a schedule, decontrolled, removed from control, rescheduled, or transferred from one schedule to another. 12
  • 13. Proceedings to add, delete, or change the schedule of a drug or other substance may be initiated by the  Drug Enforcement Administration  (DEA), the Department of Health and Human Service  (HHS) The DEA also may begin an investigation of a drug at any time based upon information received from law enforce -ment laboratories, state,local law enforcement andregulatory agencies, or 13
  • 14. DEA(data) HHS Administrator request    drug to Assistant  be controlled secretaryHealth HHS or not   commissioner Evaluation from  FDA NIDA 14
  • 15. Once the DEA has collected the necessary data, the Administrator of the Drug Enforcement Association, by authority of the Attorney General, requests from the HHS a scientific and medical evaluation and recommendation as to whether the drug or other substance should be controlled or removed from control. This request is sent to the Assistant Secretary of Health of the HHS,  Then, the HHS solicits information from the Commissioner of the Food and Drug Administration and 15
  • 16. and evaluations and recommendations from the National Institute on Drug Abuse,  and on occasion, from the scientific and medical community. The Assistant Secretary, by authority of the Secretary, compiles the information and transmits back to the DEA a medical and scientific evaluation regarding the drug or other substance, a recommendation as to whether the drug should be controlled, and in what schedule it should be placed. 16
  • 17. Every schedule otherwise requires finding and specifying the "potential for abuse" before a substance can be placed in that schedule.[16]The specific classification of any given drug or other substance is usually a source of controversy, as is the purpose and effectiveness of the entire regulatory scheme. "The term 'controlled substance' means a drug or other substance, or immediate precursor, included in schedule I, II, III, IV, or V . The term does not include distilled spirits, wine, malt beverages, or tobacco, as those terms are defined or used in subtitle E of the Internal Revenue Code of 1986." 21 U.S.C. § 802(6) 17
  • 18. 18